Drug trio improved effectiveness of cancer treatment, protected heart
Tuesday, November 6, 2012 - 15:50
in Health & Medicine
Combining either sildenafil or rapamycin with cancer medication doxorubicin protected the heart from damage and improved doxorubicin's ability to kill cancer cells. Combining all three -- sildenafil, rapamycin and doxorubicin increased these protective benefits. Researchers believe the combination therapy could potentially improve the life expectancy of cancer patients.